If beta cells are not completely gone…and if part of the problem is that they’re being held behind molecular brakes…

Then the next logical question is:

Can those brakes be released?

And if they can—

What actually happens when beta cells are pushed to proliferate again?

From Restraint to Activation

In the previous section, we looked at the major systems that keep adult beta cells from dividing:

• DYRK1A holding NFAT out of the nucleus

• GSK-3β suppressing growth signaling

• The DREAM complex locking cells into quiescence

These systems aren’t hypothetical—they’re active regulators.

So regeneration doesn’t begin by “adding growth.”

It begins by removing inhibition.

DYRK1A Inhibition — Opening the Gate

One of the most well-documented breakthroughs in this area came with the discovery that inhibiting DYRK1A can reopen the beta-cell cell cycle.

Compounds like harmine have been shown to:

• Inhibit DYRK1A

• Allow NFAT to translocate into the nucleus

• Activate genes involved in:

  • cell cycle entry

  • proliferation

  • beta-cell expansion

Studies have demonstrated that human beta cells—long considered nearly incapable of replication—can increase proliferation rates significantly under these conditions (Shen et al., 2015; Wang et al., 2015).

What This Means

This changes the narrative.

It suggests:

Adult human beta cells are not permanently locked. They are conditionally restrained.

And when the right molecular switches are flipped—

they can re-enter the cycle.

But There’s a Catch

This is where things get interesting—and where most simplified narratives fall apart. Because opening the cell cycle is only one piece of the puzzle.

When beta cells are pushed to proliferate:

• Not all of them maintain their identity

• Not all of them function properly

• Not all of them survive long-term

In other words:

The Proliferation–Function Tradeoff

Research has consistently shown that there is a tension between:

• growth (cell cycle entry)

• and function (insulin production and responsiveness)

When beta cells are driven into proliferation:

• Expression of key identity markers (Pdx1, MafA) can decrease

• Insulin production may temporarily decline

• Cells may adopt a more immature phenotype

This is not a flaw—it’s biology.

Many cell types must partially dedifferentiate to divide.

Implication

A proliferating beta cell is not the same as a mature beta cell.

And if the environment doesn’t support re-maturation— those new cells may remain functionally incomplete.

Why Environment Matters

This is where every individual's broader metabolic framework comes into play.

Because once the proliferation switch is turned on, the outcome depends on:

• Redox balance → determines oxidative damage

• Mitochondrial function → determines energy availability

• ER capacity → determines protein folding ability

• Calcium regulation → determines insulin release

• Immune tone → determines survival

If these systems are compromised:

• New cells may be:

  • unstable

  • short-lived

  • poorly functional

Synergistic Pathways: DYRK1A Is Not Alone

While DYRK1A inhibition is one of the most direct ways to stimulate proliferation, it doesn’t operate in isolation.

Other pathways influence whether proliferation occurs—and whether it succeeds:

GLP-1 / Incretin Signaling

• Enhances beta-cell survival

• Supports proliferation signals

• Improves insulin gene transcription

• Suppresses alpha cell expression, isolating beta cell specific growth

This is why combining DYRK1A inhibition with incretin signaling has shown synergistic effects in some studies.

Wnt / β-Catenin Pathway

• Promotes growth and differentiation

• Suppressed by GSK-3β

• Reactivation supports beta-cell expansion

PI3K / Akt Signaling

• Central to:

  • survival

  • growth

  • metabolism

AMPK / mTOR Balance

• Regulates:

  • energy availability

  • growth vs conservation

What This Tells Us

Beta cell proliferation is not controlled by a single switch. It is a network event.

The Risk of Forcing the System

This is where restraint is important.

Because if proliferation is forced in the absence of proper regulation:

• Cells may grow without proper function

• Stress may increase

• Long-term stability may decrease

There are also broader considerations:

• Uncontrolled proliferation in any tissue raises concerns about dysregulated growth (Re: cancer)

• Balance between growth and control must be preserved

The goal is not to force the pancreas to grow. It is to create conditions where growth becomes appropriate again.

A More Complete Model of Regeneration

Putting it all together we have to realize that regeneration is not a single event. It is a sequence.

True regeneration requires:

1. Releasing inhibitory signals

2. Providing growth signals

3. Supporting cell identity

4. Stabilizing the environment

5. Allowing maturation to occur

Closing Thought

The discovery that adult human beta cells can be coaxed back into proliferation is one of the most important shifts in diabetes research.

But it comes with an equally important realization:

Making new cells is not the hard part. Making them functional, stable, and integrated is.

And that brings us to the next critical question:

📚 References — Section 3: Reopening the Cell Cycle

• Aguayo-Mazzucato C, van Haaren M, Mruk M, Lee TB Jr, Crawford C, Hollister-Lock J, Sullivan BA, Johnson JW, Ebrahimi A, Dreyfuss JM, Van Deursen J, Weir GC, Bonner-Weir S.β Cell aging markers have heterogeneous distribution and are induced by insulin resistance. Cell Metab. 2017;25(4):898–910.

• Buteau J, Foisy S, Joly E, Prentki M.Glucagon-like peptide-1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 2003;52(1):124–132.

• Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF.Human β-cell proliferation and intracellular signaling. Endocr Rev. 2012;33(6): 911–933.

• Rulifson IC, Karnik SK, Heiser PW, et al.Wnt signaling regulates pancreatic β cell proliferation. Proc Natl Acad Sci U S A. 2007;104(15):6247–6252.

• Shen W, Taylor B, Jin Q, et al.Inhibition of DYRK1A and GSK3β induces human β-cell proliferation. Cell Metab. 2015;21(6): 1–13.

• Talchai C, Xuan S, Lin HV, Sussel L, Accili D.Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell. 2012;150(6):1223–1234.

• Wang P, Fiaschi-Taesch NM, Vasavada RC, Scott DK, Garcia-Ocaña A, Stewart AF.A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic β cell replication. Nat Med. 2015;21(4):383–388.

• Wang P, Alvarez-Perez JC, Felsenfeld DP, et al.Adenosine kinase inhibition promotes pancreatic β-cell replication. Nat Commun. 2019;10: 1–12.

• Wang W, Liu H, Wang Y, et al.Disruption of the DREAM complex enables proliferation of adult human pancreatic β cells. Nature. 2022; 1–6.